Podcasts about o neill institute

President Biden has released a health care plan that proposes reducing the age of eligibility for Medicare to 60 years and introducing a public option. Larry Levitt, MPP, Executive Vice President for Health Policy at the Kaiser Family Foundation, JAMA Associate Editor Karen Joynt Maddox, MD, MPH, Co-Director of the Center for Health Economics and Policy (CHEP) at Washington University School of Medicine, and Lawrence O. Gostin, JD, from the O’Neill Institute for National and Global Health Law at Georgetown University discuss prospects for health care reform under the new administration. Recorded January 21, 2021. Related Article(s): Moving Patient Care Forward in the Biden Era

Shelly Weizman is the Associate Director of the Addiction and Public Policy Initiative at the O’Neill Institute for National and Global Health Law and an Adjunct Professor of Law at Georgetown University Law Center. She works on a project portfolio focused on the opioid epidemic, addiction policies, barriers to treatment for substance use disorders, public health approaches to drug policies and how law can promote access to treatment and support recovery. Before joining the Institute, Ms. Weizman worked as the Assistant Secretary for Mental Hygiene in the Office of Governor Andrew Cuomo of New York. In that role, she oversaw New York State’s efforts to address the opioid epidemic as well as policy and operations related to addiction, mental health and developmental disabilities. Prior to joining the Governor’s office, Ms. Weizman served as Policy Director for Managed Care at the New York State Office of Mental Health, where she focused on developing and implementing systemic reforms within New York’s public mental health system. Shelly and James discuss her unique recovery journey that began during her teenage years while she was still in high school and how her experiences have led her to dedicating her career to driving change both through education and the public sector.

The laws and systems dealing with addiction and mental health are in need of a radical overhaul. Our guest this week has dedicated her life to the cause. Listen and learn what she doing to help change the landscape and get inspired to fight for changes in your community. Shelly Weizman is the Associate Director of the Addiction and Public Policy Initiative at the O’Neill Institute for National and Global Health Law and an Adjunct Professor of Law at Georgetown University Law Center. She works on a project portfolio focused on the opioid epidemic, addiction policies, barriers to treatment for substance use disorders, public health approaches to drug policies and how law can promote access to treatment and support recovery.Before joining the Institute, Ms. Weizman worked as the Assistant Secretary for Mental Hygiene in the Office of Governor Andrew Cuomo of New York. In that role, she oversaw New York State’s efforts to address the opioid epidemic as well as policy and operations related to addiction, mental health and developmental disabilities. Prior to joining the Governor’s office, Ms. Weizman served as Policy Director for Managed Care at the New York State Office of Mental Health, where she focused on developing and implementing systemic reforms within New York’s public mental health system.Previously, Ms. Weizman served as a Senior Staff Attorney at MFY Legal Services, a not-for-profit legal services organization in New York City. At MFY, she led efforts to expand and enforce the rights of people with psychiatric and physical disabilities, promote deinstitutionalization, and improve government oversight and accountability through legislative and regulatory reform, community organizing, and federal and state civil rights litigation. Ms. Weizman also provided advice and representation to hundreds of individual clients on civil legal matters including eviction prevention, access to health care and transportation, and individual civil rights matters.Ms. Weizman received her JD with a concentration in Health Law and Policy from Seton Hall University School of Law and her BA from the University of Houston.--

The international hunt for a COVID-19 vaccine is the most consequential medical challenge of the 21st century. The race is marked by both intense collaboration among scientists and fierce competition between governments – particularly between China and the US. As coronavirus cases mount and economies limp through lockdowns, nations are not just competing for a life-saving vaccine – they’re jockeying for political glory and a leg up on the rest of the world. And even after a vaccine is developed, count on clashes over adequate and ethical distributions. Professor Lawrence Gostin joins Altamar to discuss the geopolitics of the global vaccine race – and how countries can mitigate winner-take-all risks. Gostin is the Director of the O’Neill Institute for National and Global Health Law at Georgetown University and Director of the World Health Organization’s Collaborating Center on National and Global Health Law. He is also a Professor of Public Health at Johns Hopkins University. ----- Produced by Simpler Media

President Trump says the U.S. is leaving the World Health Organization. What it might mean for public health in the U.S. and the world.Guest: Lawrence Gostin, Director of the O’Neill Institute for National and Global Health LawRead a transcript of the episode and learn more about the WHO on our website: https://tradeoffs.org/2020/07/09/leaving-the-who/Stay on top of all our coverage of the coronavirus outbreak and our conversations with people who are being forced to make difficult decisions in the midst of it all, visit http://bit.ly/coronavirustradeoffs. Get more Tradeoffs in your inbox every Friday with our weekly newsletter: http://bit.ly/tradeoffsnewsletterFollow us on Twitter: https://twitter.com/tradeoffspod See acast.com/privacy for privacy and opt-out information.

International cooperation and multilateral approaches are being strained by rising populism and nationalism. The unabated march of the novel coronavirus (COVID19) across the globe threatens to further entrench unilateral approaches and nationalistic attitudes at a time when a global response is needed to combat this pandemic. Yet, we see travel bans being introduced, countries closing their boarders, schools and offices closing their doors, and shortages of medical and household supplies on the rise. COVID19 is the most recent example of how seemingly unpolitical and unideological issues can be politicized, becoming a potentially decisive matter such as this year’s US presidential elections. In this episode, Joel Sandhu from the Global Public Policy Institute (GPPi) talks with Mara Pillinger about what makes COVID19 so different from other epidemics and pandemics. Mara explains the difference between an epidemic and pandemic; whether travel bans could work to tackle COVID19; whether she thinks the US is doing enough to prepare itself for the pandemic; and now that its 2020, what impact is this pandemic going to have on the upcoming US elections. Mara is an Associate at the O’Neill Institute for National and Global Health Law at Georgetown Law School in Washington, DC where she is part of the Global Health Policy and Governance Initiative. Her research focuses on the political, organizational and power dynamics at work behind the scenes of the World Health Organization and major multisectoral global health partnerships.

In 2016, the World Health Organization announced that a single full dose of yellow fever vaccine would provide lifelong protection from the virus. However, due to global shortages and complicated production requirements, there has not been sufficient supply to meet the demands of recent outbreaks. Angola and the Democratic Republic of Congo in 2016 and now Brazil in 2018 have turned to using fractional doses, or about 1/5 of a full dose, as a stopgap measure—these diluted doses are only known to offer one year of protection against the virus. In this episode of Take as Directed, Daniel Lucey, a senior scholar with the O’Neill Institute for National and Global Health Law at Georgetown University, joins us to discuss the threat of yellow fever, our lack of preparedness, and the potential for a significant outbreak in Asia.   Hosted by Steve Morrison. Produced by Alex Bush. Edited by Ribka Gemilangsari.

Speaker: Dr Mark Dybul, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Dr Dybul has worked on HIV and public health for more than 25 years as a clinician, scientist, teacher and administrator. After graduating from Georgetown Medical School in Washington DC, Dybul joined the National Institute of Allergy and Infectious Diseases, where he conducted basic and clinical studies on HIV virology, immunology and treatment optimisation, including the first randomised, controlled trial with combination antiretroviral therapy in Africa. Dybul became a founding architect and driving force in the formation of the President’s Emergency Plan for AIDS Relief, better known as PEPFAR. After serving as Chief Medical Officer, Assistant, Deputy and Acting Director, he was appointed as its leader in 2006, becoming U.S. Global AIDS Coordinator, with the rank of Ambassador at the level of an Assistant Secretary of State. He served until early 2009. Before coming to the Global Fund, Dybul was co-director of the Global Health Law Program at the O’Neill Institute for National and Global Health Law at Georgetown University, where he was also a Distinguished Scholar. Dybul has written extensively in scientific and policy literature, and has received several Honorary Degrees and awards. The Harold Mitchell Development Policy Annual Lecture Series, of which this is the fourth, has been created to provide a forum at which the most pressing development issues can be addressed by the best minds and most influential practitioners of our time. This lecture was presented by the Development Policy Centre at Crawford School of Public Policy, with generous support from the Harold Mitchell Foundation.